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ABSTRACT
Objectives. To evaluate the distribution and impact of ABO blood groups on postoperative outcomes in
patients undergoing surgery for acute type A aortic dissection (ATAAD). Design. A total of 1144 surgical
ATAAD patients from eight Nordic centres constituting the Nordic consortium for acute type A aortic
dissection (NORCAAD) were analysed. Blood group O patients were compared to non-O subjects. The
relative frequency of blood groups was assessed with t-distribution, modified for weighted proportions.
Multivariable logistic regression was performed to identify independent predictors of 30-day mortality.
Cox regression analyses were performed for assessing independent predictors of late mortality. Results.
There was no significant difference in the proportions of blood group O between the study populations
in the NORCAAD registry and the background population (40.6 (95% CI 37.7–43.4)% vs 39.0 (95% CI
39.0–39.0)%). ABO blood group was not associated with any significant change in risk of 30-day or late
mortality, with the exception of blood group A being an independent predictor of late mortality.
Prevalence of postoperative complications was similar between the ABO blood groups. Conclusions. In
this large cohort of Nordic ATAAD patients, there were no associations between ABO blood group and
surgical incidence or outcomes, including postoperative complications and survival.
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Introduction
Acute type A aortic dissection (ATAAD) is associated with
numerous risk factors, including hypertension, age, athero-
sclerosis and smoking [1,2]. It is well-known that different
ABO blood groups are associated with altered risks of ven-
ous thromboembolism and occlusive arterial disease [3–7],
but the impact of blood groups in the setting of ATAAD
and associated surgery has not been evaluated.
In a previous study, it was reported that blood group O
may be over-represented in patients with abdominal aortic
aneurysm [8] but in a more recent study of more than two
million Swedish blood donors and recipients of blood trans-
fusions, no certain association was observed between blood
group and the incidence of aortic aneurysms or aortic
dissection (Zindovic et al. ABO blood group and aortic dis-
ease- A nation-wide cohort study. Manuscript in prepar-
ation). Additionally, without a clear understanding of the
mechanism, it has been reported that blood group AB is
associated with improved long-term survival after cardiac
surgery [9,10].
The aim of the present study was to evaluate the distri-
bution of ABO blood groups and their impact on surgical
outcomes in a large, well-defined cohort of ATAAD patients
from The Nordic Consortium for Acute Type A Aortic
Dissection (NORCAAD) database.
Materials and methods
This study was approved by the institutional review board
of each participating centre.
Study design
This was a retrospective, multicentre study based on the
NORCAAD registry of patients who underwent surgery for
ATAAD from 1 January 2005 to 31 December 2014 at eight
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tertiary centres in Denmark, Finland, Iceland, and Sweden.
As previously described, 194 clinical variables were collected
and up until 2014, a total of 1159 patients were included in
the registry [11].
Blood group data
For comparison of blood group distribution, blood groups of
the background population were collected from several sour-
ces. The distribution of blood groups from Finland was
obtained from the Finnish Red Cross Blood Service (www.
bloodservice.fi) and national data was used for both of the
Finnish sites. The distributions of the population of Iceland
were acquired from the Blood Bank of the National
University Hospital, Reykjavik, Iceland [12] and information
on blood groups from the Swedish and Danish populations
were collected from the Scandinavian Donations and
Transfusions database (SCANDAT2) [13]. Separate distribu-
tions were obtained for the catchment areas of all four
Swedish sites, whereas national data was used for the single
Danish site. SCANDAT2 data relied on any individuals whose
blood group was determined for any cause (e.g. preoperative
blood typing, donation of blood or need for transfusion)
whereas remaining sources were based on blood donor data.
Definitions and endpoints
Primary endpoints were the proportion of blood group O in
the study sample and the association between blood group
O with 30-day mortality and late mortality. Outcomes in
relation to specific blood groups, as well as postoperative
complications were regarded as secondary endpoints.
Acute aortic dissections were defined as those instances
in which surgery was performed within 14 days of symptom
onset. Malperfusion was defined as end-organ ischemia,
branch vessel obstruction or occlusion as described previ-
ously [14] and Penn classes were defined as Aa, absence of
organ ischemia; Ab, localised ischemia; Ac, generalised
ischemia; or Abc, localised and generalised ischemia
together. Hypotensive shock was defined as systolic blood
pressure< 90mmHg, regardless of etiology. In-hospital mor-
tality was defined as death during index admission at the
operating hospital, 30-day mortality as death within 30 days
of surgery and late mortality as all-cause mortality more
than 30 days after surgery. Major bleeding was a modified
version of the composite variable used in the BART study
[15] and defined as one or more of the following: reopera-
tion due to bleeding, chest tube output >1500mL within
the first 12 hours, >10 units (U) of red blood cell transfu-
sions or death due to bleeding. Perioperative MI was
defined as postoperative CK-MB >70 lg/l, new Q wave or
left bundle branch block on EKG. Postoperative stroke was
defined as a permanent neurological injury with or without
CT confirmation. Coma was defined as unconsciousness
lasting more than 24 hours, not attributable to sedation.
Surgical procedures
As reported in detail elsewhere, median sternotomy, cardio-
pulmonary bypass, and intermittent cardioplegic arrest were
routinely used [11]. The site of cannulation is varied by
centre, patient, and surgeon. In most instances, open distal
surgical repair was performed including resection and
inspection of the aortic arch under deep (<20 C) or mod-
erate (21–30 C) hypothermic circulatory arrest, with or
without the use of selective cerebral perfusion. The extent of
distal repair depended on the extent of dissection and the
location of the intimal tear. Surgery requiring re-implant-
ation of any supra-aortic branches was considered an arch
procedure. Aortic valve replacement or total root replace-
ment was performed when necessary and when possible the
competence of the aortic valve was restored via subcommis-
sural plication, commissural resuspension, or valvuloplasty.
Concomitant procedures (e.g. coronary artery bypass) were
performed when required.
Statistical analysis
Categorical data were given as proportions and continuous
variables were expressed as mean ± standard deviation (SD).
Normally distributed data was presented as mean ± standard
deviation (SD) whereas medians and interquartile ranges
(IQRs) were reported in skewed distributions. Groups were
compared using chi-square test and Mann-Whitney U test.
Trends were analysed using Linear-by-Linear association.
The proportion of individuals with blood group O in the
background population was estimated from the distribution
of blood types in the different regions. The proportion for
each region was weighted according to the region’s contri-
bution to the NORCAAD database providing a weighted
proportion for the background population. In turn, the pro-
portion of group O in the background population was com-
pared to the proportion in the NORCAAD database using a
confidence interval (CI) based on t-distribution, modified
for weighted proportions. Univariable and multivariable
logistic regression analyses were performed to evaluate inde-
pendent predictors of 30-day mortality. Due to the risk of
multicollinearity, malperfusion was assessed using only the
“any malperfusion” variable. With regard to blood groups,
blood group O vs non-O and the individual blood groups
(O, A, B, and AB) were analysed in separate models.
Remaining variables constituted the baseline model and the
model with “blood group O vs non-O” constituted the
default analysis. Predictors of late mortality in 30-day survi-
vors were analysed using the Cox proportional hazard
regression. Independent predictors remaining at the last
steps of each model were re-evaluated using the enter
method and the proportional hazards assumptions were
verified with adequate diagnostic tools. No adjustments to
meet the assumptions were necessary for any variable.
The regression models relied on complete case analysis
(98.8% and 98.0% of possible cases in the multivariable
logistic regression and Cox regression, respectively) and
missing cases are presented in Supplementary Tables 1 and
2. The inclusion criterion for the full regression model was
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p .100 and the limit for stepwise backward elimination
was p .100. Statistically significant variables (p< .05) at the
last step were re-evaluated using the enter method. Blood
group variables were forced into the models. The results of
the logistic regression analyses were expressed as odds ratios
(ORs) and those of the Cox regression analysis as hazard
ratios (HRs), both with 95% confidence intervals (CIs). Any
p-value< .05 was considered statistically significant.
Statistical analysis relied on standard software (IBM SPSS
Statistics for Mac, version 24.0, released 2016; IBM Corp.,
Armonk, NY).
Results
Study population and follow-up
Up until December 2014, a total of 1,159 patients were
included in the NORCAAD registry. ABO blood group was
available for 1146 patients, who constituted the study popu-
lation. Follow-up of the study cohort, performed in January
2015, was 98.1% complete with a mean follow-up time
of 3.1 ± 2.9 years.
Blood group distribution
The ABO blood group distributions in the NORCAAD data-
base and the background population are presented in
Table 1. There was no significant difference in the propor-
tions of blood group O between the study populations. In
the NORCAAD registry, 40.6% of the patients had blood
group O with an estimated 95% CI of 37.7–43.4% and in
the background population, 39.0 (95% CI 39.0–39.0)% were
blood group O patients.
Baseline and surgical characteristics
Baseline data and surgical characteristics for the study popu-
lation were similar between blood group O and non-O
patients (Table 2). Data specific for each blood group is pre-
sented in Supplementary Table 3.
Mortality and postoperative complications
Blood group O patients had significantly lower intraopera-
tive mortality than did non-O patients (5.4% vs 8.7%,
p¼ .036), whereas 30-day mortality was similar between the
groups (17.2% vs 17.7%, p¼ .829). In multivariable
Table 1. Blood group distributions in the NORCAAD registry and the background populations by country or site, according to which was available.
NORCAAD
Blood group
Denmark
(N¼ 163)
Finland
(N¼ 124)
Iceland
(N¼ 30)
Gothenburg
(N¼ 242)
Lund
(N¼ 226)
Orebro
(N¼ 100)
Stockholm
(N¼ 261)
O 73 (44.8) 36 (29.0) 17 (56.7) 100 (41.3) 102 (45.1) 32 (32.0) 105 (40.2)
A 69 (42.3) 58 (46.8) 8 (26.7) 105 (43.4) 88 (38.9) 47 (47.0) 124 (47.5)
B 14 (8.6) 21 (16.9) 4 (13.3) 23 (9.5) 27 (11.9) 17 (17.0) 24 (9.2)
AB 7 (4.3) 9 (7.3) 1 (3.3) 14 (5.8) 9 (4.0) 4 (4.0) 8 (3.1)
Background population
Blood group
Denmark
(N¼ 988705)
Finland
(N¼ 80880)
Iceland
(N¼ 7528)
Gothenburg
(N¼ 536229)
Lund
(N¼ 511562)
Orebro
(N¼ 129257)
Stockholm
(N¼ 755216)
O 416581 (42.1) 27141 (33.6) 4316 (57.3) 209200 (39.0) 201982 (39.5) 47665 (36.9) 285227 (37.8)
A 419228 (42.4) 33413 (41.3) 2347 (31.2) 238974 (44.6) 225189 (44.0) 59499 (46.0) 333234 (44.1)
B 107393 (10.9) 13792 (17.0) 662 (8.8) 61806 (11.5) 59553 (11.6) 15079 (11.7) 95825 (12.7)
AB 45503 (4.6) 6534 (8.1) 199 (2.6) 26249 (4.9) 24838 (4.9) 7014 (5.4) 40930 (5.4)
Values are expressed as number (percentage).
Table 2. Baseline and surgical characteristics of the study population, strati-
fied per blood group O and non-blood group O patients.
Characteristic Non-O (N¼ 681) O (N¼ 465) p
Age 61.7 ± 12.1 61.3 ± 12.2 .571
Male gender 453 (66.5) 322 (69.2) .333
Hypertension 370 (54.3) 226 (48.6) .057
History of aortic aneurysm 66 (9.7) 42 (9.0) .708
Connective tissue disease 29 (4.3) 25 (5.4) .381
Diabetes mellitus 15 (2.2) 11 (2.4) .856
History of stroke 22 (3.2) 23 (4.9) .142
Chronic kidney disease 11 (1.6) 10 (2.2) .507
COPD 39 (5.7) 29 (6.2) .720
DeBakey type 1 502 (73.7) 341 (73.3) .886
Intramural hematoma 54 (7.9) 37 (8.0) .987
Hypotensive shock 146 (21.4) 87 (18.7) .260
Cardiac arrest 37 (5.4) 20 (4.3) .387
Malperfusion 231 (33.9) 147 (31.6) .415
Cardiac malperfusion 55 (9.0) 39 (9.0) .995
Cerebral malperfusion 51 (8.4) 38 (9.1) .718
Renal malperfusion 44 (7.3) 20 (4.8) .105
Gastrointestinal malperfusion 20 (3.3) 15 (3.6) .811
Peripheral malperfusion 132 (21.9) 71 (17.0) .053
Penn Class .982
Aa 367 (53.9) 254 (54.6)
Ab 165 (24.2) 105 (22.6)
Ac 112 (16.4) 81 (17.4)
Abc 37 (5.4) 25 (5.4)
Proximal surgical technique .479
Supracoronary graft 472 (69.3) 331 (71.2)
Supracoronary graftþAVR 20 (2.9) 12 (2.6)
Bentall procedure 160 (23.5) 106 (22.8)
Distal surgical technique .829
Ascending aorta 479 (71.6) 330 (71.3)
Hemiarch procedure 140 (20.9) 104 (22.5)
Arch procedure 41 (6.1) 24 (5.2)
CPB time, min 194 (155–241) 188 (157–230) .258
Cross-clamp time, min 95 (68–134) 88 (63–126) .077
HCA time, min 27 (20–36) 26 (20–34) .252
Lowest core temperature, C 19.9 (18–24) 19 (18–24) .413
Values are expressed as number (percentage), as median (interquartile range
(IQR), or mean ± standard deviation (SD).
COPD: chronic obstructive pulmonary disease; AVR: aortic valve replacement;
CPB: cardiopulmonary bypass; HCA: hypothermic circulatory arrest.
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regression analysis, blood group O was not identified as an
independent predictor of 30-day mortality [OR 1.030
(0.720–1.473), p¼ .871] (Tables 3–4; Supplementary Table
5). There were no differences between groups in frequency
of major bleeding (37.2% vs 40.4%, p¼ .279) or reoperation
for bleeding (18.7% vs 21.8%, p¼ .203). Apart from blood
group O patients having a significantly lower occurrence of
postoperative deep sternal wound infections (0.7% vs 3.5%,
p¼ .002), the rates of other major postoperative complica-
tions were similar between the groups. Data per specific
blood group is presented in Supplementary Table 4.
In 30-day survivors, there was a non-significant trend
towards blood group O having a protective effect on late
mortality [HR 0.686 (0.465–1.012), p¼ .058] (Table 5;
Supplementary Table 6) and blood group A was identified
as an independent predictor of late mortality [HR 1.543
(1.027–2.319), p¼ .037].
Discussion
The present study, which is, to our knowledge, the first to
analyse the impact of ABO blood group in surgically treated
ATAAD patients, could not demonstrate any association
between ABO blood groups and the risk of undergoing
ATAAD surgery or surgical outcomes.
ABO blood group antigens are expressed by erythrocytes,
as well as by endothelial cells, and, like other surface carbo-
hydrate molecules, may have roles in cell membrane integ-
rity and cell adhesion [16–18]. Glycosylation of the aortic
wall plays a key role in normal vascular biology and altera-
tions in glycosylation of the vascular endothelium have been
identified as a risk factor for the development of cardiovas-
cular disease [19]. Recently, Avdic et al. speculated that gly-
cated cross-links rendered the aortic wall more resilient to
dilatation and dissection, which could explain a 25% risk
reduction for the development of aortic aneurysms and a
47% reduction of risk of aortic dissection in patients with
diabetes mellitus type II [20]. In a previous study, Fatic et.
al. demonstrated that blood group O was more common in
patients with AAA as compared with a sample from the
background population [8]. By contrast, a recent epidemio-
logical study of more than two million Swedish citizens
showed no certain association between blood groups and
aortic disease, with an incidence risk ratio for aortic dissec-
tion of 0.89 (95% CI 0.78–1.01) in non-O donors compared
with blood group O donors (Zindovic et al. ABO blood
group and aortic disease- A nation-wide cohort study.
Manuscript in preparation). Considering the results of the
current report, it is likely that the glycosylation patterns of
N-acetylgalactosamine and D-galactose, the determinants of
ABO blood group, do not have a significant effect on the
strength of the aortic wall and thus do not influence the
risk of aortic dissection in the general population.
It has been reported that up to 49% of patients with
ATAAD die prior to reaching the hospital [21], with the
first 24 hours after symptom onset being associated with sig-
nificant mortality and defined as a “hyperacute” state by
Booher et al. [22]. Preoperative malperfusion is associated
with increased mortality in ATAAD patients [14], while
bleeding, cardiac failure, and stroke have been identified as
the leading causes of in-hospital deaths [23,24]. Since it has
been demonstrated that blood group O patients are at a
lower risk for both venous and arterial thromboembolism,
including myocardial infarction and cerebrovascular stroke
[3], it could be speculated that this would have an impact
on mortality after ATAAD surgery. The current study
showed that blood group O patients were at a lower risk for
intraoperative mortality in univariable analysis, however, in
Table 3. Early mortality and postoperative complications in the population,
presented per blood group O and non-blood group O patients.
Characteristic Non-O (N¼ 681) O (N¼ 465) p
Intraoperative mortality 59 (8.7) 25 (5.4) .036
30-day mortality 120 (17.7) 80 (17.2) .829
In-hospital mortality 110 (16.2) 74 (15.9) .889
Major bleeding 275 (40.4) 173 (37.2) .279
Reoperation for bleeding 144 (21.8) 85 (18.7) .203
Perioperative MI 41 (6.2) 30 (6.6) .795
Postoperative stroke 108 (16.4) 68 (14.8) .487
Postoperative coma 59 (9.9) 45 (11.1) .517
RRT 83 (12.6) 46 (10.1) .204
Mesenteric ischemia 31 (5.2) 23 (5.7) .745
DSWI 23 (3.5) 3 (0.7) .002
Acute limb ischemia 30 (4.6) 13 (2.9) .147
Ventilatory support >48 h 221 (34.1) 131 (29.0) .076
Cardiac tamponade 93 (14.1) 65 (14.3) .927
Postoperative CKMB 25 (15–46) 26 (15–43) .809
Postoperative Lactate 3.0 (2.1–4.3) 2.9 (2.1–4.3) .156
Length of stay in ICU, days 4 (2–7) 3 (2–7) .329
Values are expressed as number (percentage), or as median (IQR).
MI: myocardial infarction; RRT: renal replacement therapy; DSWI: deep sternal
wound infection; ICU: intensive care unit.
Table 4. Independent predictors of 30-day mortality.
Characteristic OR (95% CI) p
Diabetes mellitus 3.929 (1.499–10.299) .005
COPD 2.705 (1.446–5.060) .002
Cardiac arrest 3.368 (1.803–6.290) <.001
Malperfusion 2.759 (1.936–3.933) <.001
CPB-time, min 1.007 (1.005–1.009) <.001
Blood group O (vs Non-O) 1.030 (0.720–1.473) .871
Blood group
O ref.
A 1.105 (0.757–1.613) .606
B 0.743 (0.400–1.378) .346
AB 0.447 (0.154–1.302) .140
Values are expressed as Odds ratios (OR:s) and 95% Confidence intervals (CI).
COPD: chronic obstructive pulmonary disease.
Table 5. Independent predictors of late mortality in 30-day survivors.
Characteristic HR (95% CI) p
Age 1.061 (1.041–1.081) <.001
Chronic kidney disease 2.997 (1.300–6.907) .010
COPD 1.837 (1.025–3.292) .041
Blood group O (vs Non-O) 0.686 (0.465–1.012) .058
Blood group
O ref.
A 1.543 (1.027–2.319) .037
B 1.056 (0.549–2.029) .871
AB 1.720 (0.765–3.866) .190
Values are expressed as Hazard ratios (HR:s) and 95% Confidence inter-
vals (CI).
COPD: chronic obstructive pulmonary disease.
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a multivariable model, ABO blood group did not predict
30-day mortality in surgical ATAAD patients.
Bleeding complications after surgery for ATAAD are
associated with impaired survival and higher rates of post-
operative complications [25,26]. Compared to patients with
non-O blood group, blood group O individuals have been
shown to have 25–30% lower levels of von Willebrand factor
[27]. In theory, this could put them at higher risk of bleed-
ing in association with ATAAD surgery. However, the pre-
sent study could not demonstrate that blood group O
patients were at higher risk of bleeding complications, which
is in accordance with a previous report by Welsby et al.
showing no association between blood groups and bleeding
in 877 patients that underwent coronary artery bypass sur-
gery [9].
Previously, Welsby et al. demonstrated blood group AB
patients to be at lower risk of long-term mortality after rou-
tine cardiac surgery [10]. In contrast, our results showed a
trend towards non-O blood groups being associated with
impaired late survival, driven by blood group A, being an
independent predictor of late mortality (1.543 (1.027–2.319),
p¼ .037). This trend could be explained by non-O patients
being generally at an increased risk of cardiovascular and
thromboembolic disease [3]. After undergoing surgery,
patients with ATAAD enter a chronic state, potentially
influenced by surgical complications, malperfusion injuries
and false lumen patency. Possibly, the difference between
the two studies could be explained by thromboembolic
mechanisms having a larger impact on survival in patients
with aortic dissection when compared to those undergoing
routine procedures. Yet, in the short term, blood groups
were not associated with altered rates of postoperative car-
diovascular or thromboembolic complications.
The NORCAAD registry is one of the largest databases
on ATAAD and, as such, it has provided us the opportunity
to perform our analyses in a large and relatively homoge-
neous study sample. However, the risk of type II errors can-
not not be ruled out, but any differences between the
groups not detected by this study are most likely of minor
clinical importance. The multi-centre nature of the registry
has limited the possibility of additional review of patient
charts and exposes the inherent shortcomings of a retro-
spective database. The proportions of ABO blood groups
were compared to the background population, partly repre-
sented by blood donors from Finland and Iceland. Blood
donors tend to be younger and healthier than ATAAD
patients, but it has previously been shown that there is no
difference in the frequency of blood group O between blood
donors and significantly older and co-morbid recipients of
blood transfusions from the general population (Zindovic
et al. ABO blood group and aortic disease- A nation-wide
cohort study. Manuscript in preparation). Therefore, we
believe that the blood group distributions of the background
populations of these countries are adequately reflected by
the distribution of blood groups in blood donors. We do
not have full data on causes of death and we cannot, there-
fore, assess the causality between ATAAD and late mortal-
ity. Furthermore, despite the large study sample, we cannot
exclude that some of our analyses were under-powered.
Nevertheless, it is our opinion that the size and multi-centre
nature of the NORCAAD registry represents the true
strength of the current study.
Conclusion
The present study could not demonstrate any association
between ABO blood groups and the risk of undergoing sur-
gery for ATAAD. Furthermore, ABO blood groups did not
have any impact on rates of postoperative complications or
mortality after surgery for ATAAD.
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